Notably, a study reported better diagnostic sensitivities of CTCs for early-stage CRC than serum biochemical markers, such as carcinoembryonic antigen (CEA) or CA19-9 (Yu et al., 2020). This evidence concerns the gene CEACAM5 and colorectal carcinoma.